Decision of the EEA Joint Committee No 76/2023 of 28 April 2023 amending Annex I (Veterinary and phytosanitary matters) to the EEA Agreement [2023/2232]
Date: 2023-04-28
Institutions: EEA Joint Committee
Subjects: Abruzzi, EU reference laboratory, European Economic Area, Italy, animal disease, disease prevention, livestock, revision of an agreement, veterinary inspection, viral disease




L_202302232EN.000101.fmx.xml












Official Journal of the European Union


EN
Series L













2023/2232


9.11.2023







            DECISION OF THE EEA JOINT COMMITTEE No 76/2023
of 28 April 2023
         
amending Annex I (Veterinary and phytosanitary matters) to the EEA Agreement [2023/2232]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2022/2304 of 24 November 2022 designating the European Union reference laboratory for Rift Valley fever (1) is to be incorporated into the EEA Agreement.












(2)


This Decision concerns legislation regarding live animals other than fish and aquaculture animals. Legislation concerning these matters shall not apply to Iceland, as specified in paragraph 2 of the Introductory Part of Chapter I of Annex I to the EEA Agreement. This Decision is therefore not to apply to Iceland.












(3)


This Decision concerns legislation regarding veterinary matters. Legislation regarding veterinary matters shall not apply to Liechtenstein as long as the application of the Agreement between the European Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein, as specified in the sectoral adaptations to Annex I to the EEA Agreement. This Decision is therefore not to apply to Liechtenstein.












(4)


Annex I to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
The following is inserted after point 51 (Commission Delegated Regulation (EU) 2021/2156) in Part 3.2. of Chapter I of Annex I to the EEA Agreement:






‘52.



32022 R 2304: Commission Implementing Regulation (EU) 2022/2304 of 24 November 2022 designating the European Union reference laboratory for Rift Valley fever (OJ L 305, 25.11.2022, p. 51).
This act shall not apply to Iceland.’
                        






Article 2
The text of Implementing Regulation (EU) 2022/2304 in the Norwegian language, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 29 April 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 28 April 2023.


For the EEA Joint Committee


The President

Nicolas VON LINGEN
            





(1)  
            OJ L 305, 25.11.2022, p. 51.

(*1)  No constitutional requirements indicated.


ELI: http://data.europa.eu/eli/dec/2023/2232/oj
ISSN 1977-0677 (electronic edition)